Location: Home
  • search
  • go
  • Relate News
  • 7/17/2024Full-Life Tech, SK Biopharma Enter Licensing Deal for Novel Therapeuti...
  • 7/17/2024SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to E...
  • 7/17/2024Green Cross Sells Hong Kong Unit to China Resources Boya Bio
  • 7/17/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • 7/17/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 7/17/2024CDE Issues the Technical Guidelines for Clinical Trials of Drugs for G...
  • 7/16/2024NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...
  • 7/16/2024U.S. Senators Introduce Bill to Reduce U.S. Dependence on China for Ph...
  • 7/16/2024Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
  • 7/16/2024China's Health Supplements Market: Trends and Opportunities for Busine...
  • 7/15/2024China's Fast-following Approach Positions It at the Forefront of the F...
  • 7/15/2024China Biopharma Tracker – H1/2024 (PharmaNJ)
  • 7/15/2024Will US Clinical Study Diversity Guidance Cloud Chinese Firms' Prospec...
  • 7/15/2024China's Once-booming Online Healthcare Sector Sees Its Vital Signs Sin...
  • 7/15/2024CDE Solicits Comments on the Technical Guidelines for IVRT and IVPT St...
  • 7/15/2024Domestic Developers File for China's First Home-Made Quadrivalent HPV ...
  • 7/15/2024GenScript's US Unit Legend Biotech Reportedly Receives Takeover Approa...
  • 7/12/2024AFT in China Distribution Deal with Hainan Haiyao for Skin Infection C...
  • 7/12/2024CDE Solicits Public Comments on ICH M14 and Its Chinese Translation
  • 7/12/2024NMPA Clears CSPC's RSV Vaccine Candidate for Human Clinical Trials
  • 7/12/2024Recent Executive Moves
  • 7/12/2024Prominence of Asia in Global Pharma Clinical Trials Rising Substantial...
  • 7/11/2024Biopharma Partnership Interest with China Remains High: LEK Survey
  • 7/11/2024Political Change Around China Means Change for Pharma (The Medicine Ma...
  • 7/11/2024Eisai's Alzheimer's Drug LEQEMBI (Lecanemab) Approved in Hong Kong
  • 7/11/2024Elevar and Hengrui Aim for Quick Refile of PD-1 Liver Cancer Combo Aft...
  • 7/11/2024Ipsen and ForeseenBio Strike Global Licensing Deal for ADCs with FIC...
  • 7/11/2024Sichuan Biokin Pharma Files for US$500M Hong Kong IPO
  • 7/11/2024AusperBio AHB-137 Gains Breakthrough Status in China for CHB  
  • 7/11/2024Recent Advancements and Challenges in Cervical Cancer Prevention in Ch...
  • Page:1/718 Total number of articles:21530: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group